Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01145872 · ClinicalTrials.gov registry record · Phase 3

The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression Relapse

A Phase 3 study, sponsored by University of Denver.

Completed
Registry status
Phase 3
Development phase
92
Enrollment target

NCT01145872: Completed Phase 3 study, sponsored by University of Denver.

NCT01145872 is a Phase 3 study that has completed, run by University of Denver. The registered enrollment target is 92 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01145872, a Phase 3 study, has completed, sponsored by University of Denver.

COMPLETED
Registry status
Phase 3
Development phase
92 participants
Enrollment target

Study Summary

This research proposal is intended to elucidate the efficacy and mechanisms underlying Mindfulness Based Cognitive Therapy (MBCT) in a population in remission from recurrent Major Depressive Disorder (MDD). The first objective of the study is to replicate previous studies' findings of MBCT's effects on decreasing depressive symptoms and depression relapse rates. However, this proposal aims to make a novel contribution to the literature by using a randomized, controlled design, and comparing the effects of MBCT to an active control condition (ACC). The use of a well-designed ACC will enable us to control for confounding variables such as social support and expected outcomes, thus allowing us to determine whether elements specific to MBCT lead to its salutary effects (Aim 1). Previous MBCT studies have largely relied on self-report measurement methodologies, limiting valid conclusions about the nature of MBCT. Further, few studies have examined the mechanisms underlying effects of MBCT on depressive symptoms and relapse. Theoretical considerations and preliminary empirical evidence suggest emotional, physiological, and cognitive functioning to be promising mechanisms of MBCT. Therefore, the investigators propose to assess each of these potential mechanisms of MBCT using self-report, autonomic physiological, and reaction time tasks (Aim 2). Collectively, these aims are expected to strengthen the evidence base for MBCT while cultivating a scientific model for its effects and mechanisms on decreasing depressive symptoms and depression relapse rates.

Interventions

  • BEHAVIORAL Mindfulness Based Cognitive Therapy
  • BEHAVIORAL Health Enhancement Program

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2010-07
Est. Completion 2013-04
Phase Phase 3
University of Denver

13 total trials

What the finished NCT01145872 record still lists

NCT01145872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 2 interventions - of which Mindfulness Based Cognitive Therapy is the first listed.

NCT01145872 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01145872 about?

NCT01145872 is a clinical study titled "The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression Relapse". This research proposal is intended to elucidate the efficacy and mechanisms underlying Mindfulness Based Cognitive Therapy (MBCT) in a population in remission from recurrent Major Depressive Disorder (MDD). The first objective of the study is to replicate previous studies' findings of MBCT's effects...

What is the current status of trial NCT01145872?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 92 participants. The study started on 2010-07. Estimated completion is 2013-04.

What interventions are being tested in trial NCT01145872?

The interventions under investigation include: Mindfulness Based Cognitive Therapy (BEHAVIORAL), Health Enhancement Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT01145872?

This trial is sponsored by University of Denver, which has 13 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01145872's enrollment target sits among peer trials

92 1723rd of 2000 higher than 277 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03184545 · 92 participants · Phase 3

    Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome

  • NCT04172532 · 92 participants · Phase 1

    Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • NCT04508088 · 92 participants

    Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • NCT04840602 · 92 participants · Phase 2

    Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01145872, the US trial registry maintained by the National Library of Medicine. NCT01145872 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.